Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00968214
What this trial is testing

Study of Tumor and Blood Samples From Postmenopausal Women With Primary Breast Cancer Enrolled on Clinical Trial CAN-NCIC-MA27

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 364
Not applicableLooking for participantsNCT07095114
What this trial is testing

Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.

Who this might be right for
Ductal Carcinoma in SituStage I Breast CancerStage II Breast Cancer+1 more
Barbara Ann Karmanos Cancer Institute 30
Early research (Phase 1)Ended earlyNCT00251433
What this trial is testing

GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast Cancer

Who this might be right for
Neoplasms, Breast
Novartis Pharmaceuticals 53
Not applicableStudy completedNCT01969448
What this trial is testing

Study to Assess Perfusion and Patient Satisfaction in Nipple-Areola Mastectomy With Immediate Reconstruction

Who this might be right for
Ductal Carcinoma in Situ - CategoryBreast CancerProphylactic Mastectomy
Washington University School of Medicine 79
Not applicableUnknownNCT05099978
What this trial is testing

Asian Multicenter Prospective Study of ctDNA Sequencing

Who this might be right for
Cervical CancerOvarian Clear Cell CarcinomaNasopharyngeal Carcinoma+3 more
National Cancer Center, Japan 506
Not applicableStudy completedNCT02218385
What this trial is testing

ForeCYTE Breast Aspirator for Sample Collection and Cytological Testing of Nipple Aspirate Fluid

Who this might be right for
Breast Neoplasms
Atossa Therapeutics, Inc. 52
Early research (Phase 1)Study completedNCT00516243
What this trial is testing

Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerProgesterone Receptor-negative Breast CancerStage I Breast Cancer+3 more
National Cancer Institute (NCI) 40
Not applicableLooking for participantsNCT05573893
What this trial is testing

PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan

Who this might be right for
Breast NeoplasmsBreast CancerNeoplasm Metastasis
AstraZeneca 800
Not applicableStudy completedNCT06285747
What this trial is testing

A Correlational Study: Breast Cancer-related Chest Wall Lymphedema, Quality of Life, and Shoulder Function

Who this might be right for
Breast Carcinoma
Mayo Clinic 85
Testing effectiveness (Phase 2)Study completedNCT02018458
What this trial is testing

Safety Study Of Chemotherapy Combined With Dendritic Cell Vaccine to Treat Breast Cancer

Who this might be right for
Breast Cancer
Baylor Research Institute 10
Not applicableStudy completedNCT01896778
What this trial is testing

Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer

Who this might be right for
Adult Liver CarcinomaBreast CarcinomaColon Carcinoma+7 more
Roswell Park Cancer Institute 9
Testing effectiveness (Phase 2)Study completedNCT00811135
What this trial is testing

Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 88
Not applicableLooking for participantsNCT07723209
What this trial is testing

Radiation After No Axillary Nodal Sampling

Who this might be right for
Early-stage Breast CancerInvasive Ductal Carcinoma of Female Breast
NYU Langone Health 105
Not applicableNot Yet RecruitingNCT07809698
What this trial is testing

CT-AI Breast Cancer Opportunistic Screening Health Examination Study

Who this might be right for
Breast Neoplasms
The First Affiliated Hospital with Nanjing Medical University 30,000
Not applicableStudy completedNCT00303914
What this trial is testing

Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer

Who this might be right for
Breast CancerCognitive/Functional EffectsColorectal Cancer+4 more
Eastern Cooperative Oncology Group 2,310
Not applicableStudy completedNCT02106026
What this trial is testing

Nursing Education Intervention for Maternal Breastfeeding

Who this might be right for
Breast FeedingPostpartum Breast Disorders
Universidad Miguel Hernandez de Elche 314
Early research (Phase 1)Ended earlyNCT06264921
What this trial is testing

A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorSolid Tumor, AdultAdvanced Solid Tumor+26 more
NiKang Therapeutics, Inc. 23
Not applicableUnknownNCT04627714
What this trial is testing

Adapted Fencing in Breast Cancer: a Pilot Study

Who this might be right for
Breast Neoplasms
Central Hospital, Nancy, France 24
Testing effectiveness (Phase 2)UnknownNCT02602938
What this trial is testing

Aspirin on CTCs of Advanced Breast and Colorectal Cancer

Who this might be right for
Epithelial-Mesenchymal TransitionCirculating Tumor Cells
Zhejiang Provincial People's Hospital 40
Testing effectiveness (Phase 2)Temporarily pausedNCT06868238
What this trial is testing

Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)

Who this might be right for
Ductal Carcinoma in Situ
University of Florida 30
Next Page